Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cumberland Pharmaceuticals Inc CPIX

Healthcare
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a... see more

Recent & Breaking News (NDAQ:CPIX)

Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors

PR Newswire January 16, 2017

Cumberland Pharmaceuticals and Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect®

PR Newswire January 9, 2017

Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products

PR Newswire November 16, 2016

Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing

Canada NewsWire November 7, 2016

Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2016 Financial Results

PR Newswire November 1, 2016

Public Company Executives to Present Online to Investors on November 3

Canada NewsWire October 31, 2016

Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com November 3

Canada NewsWire October 28, 2016

Cumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results

PR Newswire October 25, 2016

Cumberland Pharmaceuticals Launches Promotion Of Ethyol® In The United States For Oncology Patient Support

PR Newswire September 26, 2016

Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support

PR Newswire August 23, 2016

Cumberland Pharmaceuticals Announces Caroline Young To Join Its Board Of Directors

PR Newswire June 10, 2016

Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results

PR Newswire May 10, 2016

Cumberland Pharmaceuticals and Clinigen Group enter into exclusive U.S. commercialization agreement for oncology support drug Ethyol®

PR Newswire May 10, 2016

Cumberland Pharmaceuticals To Announce First Quarter 2016 Financial Results

PR Newswire May 3, 2016

Cumberland Pharmaceuticals Announces New Program To Develop Vasculan(TM) For Systemic Sclerosis

PR Newswire April 27, 2016

Caldolor® Launched For The Treatment Of Pain And Fever In Children

PR Newswire March 24, 2016

Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Financial Results

PR Newswire March 3, 2016

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2015 Financial Results

PR Newswire February 25, 2016

Vaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics

PR Newswire February 10, 2016

Piramal Critical Care And Cumberland Pharmaceuticals Announce Launch Of Caldolor And Vaprisol Co-Promotion

PR Newswire January 25, 2016